Abstract
Brain targeted AAV-GALC gene therapy reduces psychosine and extends lifespan in a mouse model of Krabbe disease
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have